Your current location:HOME >health >US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition 正文
TIME:2024-05-21 20:12:09 Source: Internet compilationEdit:health
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Nadal returns to Roland Garros to practice amid doubts over fitness and form2024-05-21 20:11
Why foreign enterprises double down on investment in China2024-05-21 20:10
Tourism industry hits record highs over Spring Festival holiday2024-05-21 19:47
China registers 415 million motor vehicles, 500 million drivers2024-05-21 19:15
Not so Cool Britannia! Noel Gallagher gives damning verdict on Keir Starmer2024-05-21 19:02
Update: China's Tianwen2024-05-21 18:54
Xi to Attend Martyrs' Day Event to Pay Tribute to Fallen Heroes2024-05-21 18:50
China to lead way in clean energy shipbuilding2024-05-21 18:30
What's next for Iran after death of its president in crash?2024-05-21 17:48
U.S. plan to replace China2024-05-21 17:47
Fresh heartache for cancer2024-05-21 20:07
Update: China's Tianwen2024-05-21 19:31
Xi's Article on Advancing Chinese Modernization to Be Published2024-05-21 19:09
New advances inspire China's deep space exploration2024-05-21 18:41
Ship that caused Baltimore bridge collapse has been refloated2024-05-21 18:07
Cainiao, JD, SF among logistics firms on global march2024-05-21 18:02
East China’s Jinan endeavors to spur growth of AI industry2024-05-21 17:53
Expos back in business across nation2024-05-21 17:49
Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 20252024-05-21 17:35
China launches new satellite group2024-05-21 17:28